Clinical Trials Browser

Stomatitis, Mucositis

NCT05966194 2024-11-15

KEVLARx

Phase 2 Recruiting

216 enrolled

Head & NeckOther

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Mouth Neoplasms, Stomatitis, Mucositis

NCT03515538 2024-11-04

PREVLAR

Phase 2 Completed

53 enrolled 15 charts

Head & NeckOther

Head and Neck Neoplasms, Mouth Neoplasms, Stomatitis, Mucositis

NCT02606994 2019-02-06

TPvsM

Phase 2 Terminated

1 enrolled

Other

Neoplasms, Stomatitis, Mucositis

NCT02324335 2019-01-16

Brilacidin

Phase 2 Completed

61 enrolled 12 charts

Head & NeckOther

Head and Neck Neoplasms, Stomatitis, Mucositis

NCT02885376 2018-12-21

Study of Dentoxol® Mouthrinse for Oral Mucositis

Phase 2 Completed

108 enrolled

Other

Stomatitis, Mucositis

NCT01898091 2017-03-06

OM

Phase 2 Completed

50 enrolled 9 charts

Other

Stomatitis, Mucositis

NCT00698204 2014-06-05

Cox-2 Inhibition in Radiation-induced Oral Mucositis

Phase 2 Completed

43 enrolled 10 charts

Head & NeckOther

Head and Neck Neoplasms, Stomatitis, Mucositis

NCT00965172 2012-03-22

Caphosol in Sarcoma Patients With Mucositis

Phase 2 Completed

30 enrolled

OtherSarcoma

Neoplasms, Sarcoma, Stomatitis, Mucositis

NCT00230191 2007-01-15

Safety and Efficacy of RK0202 in Oral Mucositis

Phase 2 Completed

110 enrolled

Head & NeckOther

Head and Neck Neoplasms, Mouth Diseases, Stomatitis, Oral Ulcer, Mucositis

Clinical Trials

DARENCA4

KEVLARx

PREVLAR

TPvsM

Brilacidin

Study of Dentoxol® Mouthrinse for Oral Mucositis

OM

Cox-2 Inhibition in Radiation-induced Oral Mucositis

Caphosol in Sarcoma Patients With Mucositis

Safety and Efficacy of RK0202 in Oral Mucositis